Angioedema due to angiotensin-converting enzyme inhibitors
- 1 October 1999
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 44 (1-2) , 21-25
- https://doi.org/10.1016/s0162-3109(99)00107-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Plasma bradykinin in angio-oedemaThe Lancet, 1998
- Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcomeIntensive Care Medicine, 1997
- Recurrent Angiotensin-Converting Enzyme Inhibitor—Associated AngioedemaJAMA, 1997
- An adverse reaction to angiotensin-converting enzyme inhibitors in a patient with neglected C1 esterase inhibitor deficiencyJournal of Allergy and Clinical Immunology, 1997
- Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*Clinical Pharmacology & Therapeutics, 1996
- Angioedema of the IntestineNew England Journal of Medicine, 1996
- Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired Cl-inhibitor deficienciesImmunopharmacology, 1996
- Contraindications to the use of ace inhibitors in patients with c1 esterase inhibitor deficiencyThe American Journal of Medicine, 1991
- Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamineJournal of Allergy and Clinical Immunology, 1990
- Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodiesBlood, 1986